Live feed
Filing
SC 13D
SC 13D0001104659-21-051420·Achilles Therapeutics plc
Schedule 13D ownership disclosure
ACHILLES THERAPEUTICS PLC
Security class unavailable · CUSIP: 00449L102
Event date: 2021-04-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-051420
- Form type
- SC 13D
- Filer
- Achilles Therapeutics plc
- CIK
- CIK 1830749
- Filed
- Apr 16, 2021
- Reporting period
- Apr 06, 2021
- Description
- Schedule 13D beneficial ownership